Bufalin: a potential drug for regulating EGFR-TKIs resistance in lung cancer via the EGFR-PI3K/Akt-mTOR signaling.

布法林：一种通过 EGFR-PI3K/Akt-mTOR 信号通路调节肺癌中 EGFR-TKI 耐药性的潜在药物。